Gladius Capital Management LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 285 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.

Quarter-by-quarter ownership
Gladius Capital Management LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$35,664
+15.0%
1,098
-14.8%
0.01%
+200.0%
Q2 2022$31,0001,2880.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders